Lv51
888 积分 2023-09-07 加入
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
1小时前
待确认
Abstract 3310: The impact of TP53 mutations on immunotherapy efficacy and the immune microenvironment in NSCLC patients
5个月前
已关闭
Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline
5个月前
已完结
Transforming the understanding of brain immunity
5个月前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
6个月前
已完结
p53 at the crossroads of tumor immunity
6个月前
已完结
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)
1年前
已完结
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry
1年前
已完结
Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer
1年前
已完结
皖公网安备34019202002308
